Posted On: 03/15/2016 5:36:45 PM
Post# of 7
Celator Pharmaceuticals shares soared
more than 400% on a positive clinical update
for its experimental AML treatment .
Closed today $8.94
Nasdaq CM
Called 2/21/2016 $2.18
Website
Shares Outstanding: 34.55M
Float: 22.85M
% Held by Insiders: 37.58%
% Held by Institutions: 8.70%
Shares Short (as of Jan 29, 2016): 1.08M
Short Ratio (as of Jan 29, 2016): 5.21
Short % of Float (as of Jan 29, 2016): 4.18%
Shares Short (prior month): 788.32K
more than 400% on a positive clinical update
for its experimental AML treatment .
Closed today $8.94
Nasdaq CM
Called 2/21/2016 $2.18
Website
Shares Outstanding: 34.55M
Float: 22.85M
% Held by Insiders: 37.58%
% Held by Institutions: 8.70%
Shares Short (as of Jan 29, 2016): 1.08M
Short Ratio (as of Jan 29, 2016): 5.21
Short % of Float (as of Jan 29, 2016): 4.18%
Shares Short (prior month): 788.32K
(0)
(0)
